CANKADO at the 41st annual conference of the Deutsche Gesellschaft für Senologie

CANKADO at the 41st annual conference of the Deutsche Gesellschaft für Senologie 1

CANKADO at the 41st annual conference of the German Society of Senology Share on linkedin Share on twitter Share on facebook Share on whatsapp Munich, Germany, 04.07.22 – After two years of the pandemic, CANKADO was delighted to attend the f2f conference again. It was clearly noticeable that digitization in cancer therapy is increasingly gaining momentum. […]

ONE MILLION CANCER TREATMENT MONTHS OMCAT

ONE MILLION CANCER TREATMENT MONTHS OMCAT 5

ONE MILLION CANCER TREATMENT MONTHS (OMCAT) Share on linkedin Share on twitter Share on facebook Share on whatsapp Munich, Germany 29.06.22 – We are pleased to announce the launch of OMCAT*, the largest AI clinical trial in oncology. The vision behind this trial is to sustainably improve the care and safety of cancer patients. One […]

CANKADO’s Contribution in upcoming edition of ‘Colloquium Senologie 2021/2022’

CANKADO’s  Contribution in upcoming edition of  ‘Colloquium Senologie 2021/2022’ 7

CANKADO’s Contribution in upcoming edition of ‘Colloquium Senologie 2021/2022’ A Book Series on Practice-changing developments in breast cancer therapy Share on linkedin Share on twitter Share on facebook Share on whatsapp Cologne, Germany, 01.07.2021 – The book series ‘Colloquium Senologie’ targets all doctors that devote themselves to the care of breast cancer patients. Together with […]

Germany’s first DiGA for Breast Cancer Patients

Germany's first DiGA for Breast Cancer Patients 8

Germany’s first DiGA for Breast Cancer Patients ‘PRO-React Onco’ from CANKADO Now Approved as a Digital Health Application (DiGA)  Share on linkedin Share on twitter Share on facebook Share on whatsapp Cologne, Germany, 26.05.2021 – CANKADO’s digital health application (Digitale Gesundheitsanwendung, DiGA) called PRO-React Onco was approved by the Federal Institute for Drugs and Medical […]

CANKADO’s Digital Health Solution Assists a New Clinical Trial, ADAPTlate

CANKADO’s Digital Health Solution Assists a New Clinical Trial, ADAPTlate 9

CANKADO’s DIGITAL HEALTH SOLUTION ASSISTS NEW CLINICAL TRIAL, ADAPTlate This oncologic clinical trial evaluates the efficacy and safety of the CDK 4/6 Inhibitor Abemaciclib in combination with endocrine therapy in high-risk early breast cancer patients Share on linkedin Share on twitter Share on facebook Share on whatsapp Cologne, Germany, 07.01.2021 – CANKADO, the leading digital […]

CANKADO’s Companion-APP Solution provides Drug-Optimised Digital Applications for Pharmaceutical Companies

CANKADO’s Companion-APP Solution provides Drug-Optimised Digital Applications for Pharmaceutical Companies 10

CANKADO’s Companion-APP Solution provides Drug-Optimised Digital Applications for Pharmaceutical Companies The tool is a drug tailored extension of CANKADO’s e-Health solution Share on linkedin Share on twitter Share on facebook Share on whatsapp Cologne, Germany, 17.12.2020 – CANKADO’s Companion-APP solution provides an environment that helps to build a drug-tailored digital connected care solution for physicians […]

Substantial Expansion of CANKADO’s Digital Health Solution

digital health

SUBSTANTIAL EXPANSION OF CANKADO’s DIGITAL HEALTH SOLUTION There has been a steady increase in the usage of CANKADO e-Health system among healthcare professionals, patients and in clinical trials Share on linkedin Share on twitter Share on facebook Share on whatsapp Cologne, Germany, 05.11.2020 – CANKADO’s digital health solution is having a substantial increase in its usage […]

CANKADO e-Health support for epilepsy patients under ketogenic diet therapies in Argentina

e-health

CANKADO E-HEALTH SUPPORT FOR EPILEPSY PATIENTS UNDER KETOGENIC DIET THERAPIES IN ARGENTINA ‘My Keto Life’ is an e-Health tool developed on the CANKADO platform by a team composed of healthcare Professionals, B-LIFE: an Argentinean nutrition company and CANKADO Latin America Share on linkedin Share on twitter Share on facebook Share on whatsapp Cologne, Germany, 15.10.2020 […]

CANKADO e-Health support for institut jules bordet’s New study,StomRay

CANKADO e-Health support for institut jules bordet's New study,StomRay 13

CANKADO E-HEALTH SUPPORT FOR INSTITUT JULES BORDET’s NEW STUDY, STOMRAY The study evaluates the dental side effects of radiotherapy on head and neck cancer patients Share on linkedin Share on twitter Share on facebook Share on whatsapp Cologne, Germany, 30.09.2020 – CANKADO, the leading digital health application developers to be the e-health support for Institute […]